Assessment of response to therapy in advanced breast cancer (an amendment).
作者信息
Hayward J L, Carbone P P, Rubens R D, Heuson J C, Kumaoka S, Segaloff A
出版信息
Br J Cancer. 1978 Jul;38(1):201. doi: 10.1038/bjc.1978.182.
Abstract
摘要
相似文献
1
Assessment of response to therapy in advanced breast cancer (an amendment).晚期乳腺癌治疗反应评估（修订案）
Br J Cancer. 1978 Jul;38(1):201. doi: 10.1038/bjc.1978.182.
2
Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland.
Eur J Cancer (1965). 1978 Nov;14(11):1291-2. doi: 10.1016/0014-2964(78)90238-4.
3
Letter: Assessment of response to treatment in advanced breast cancer.信函：晚期乳腺癌治疗反应评估
Lancet. 1974 Aug 24;2(7878):465. doi: 10.1016/s0140-6736(74)91847-9.
4
Problems in hormonal therapy for advanced breast cancer.晚期乳腺癌激素治疗中的问题。
Prog Clin Biol Res. 1977;12:467-77.
5
[Bilateral adrenalectomy for advanced breast cancer].[双侧肾上腺切除术治疗晚期乳腺癌]
Harefuah. 1976 May 2;90(9):431-5.
6
Assessment of response to therapy in advanced breast cancer.晚期乳腺癌治疗反应的评估。
Br J Cancer. 1977 Mar;35(3):292-8. doi: 10.1038/bjc.1977.42.
7
Treatment and survival on advanced breast cancer.晚期乳腺癌的治疗与生存情况
Br Med J. 1978 Dec 16;2(6153):1673-4. doi: 10.1136/bmj.2.6153.1673.
8
Combination chemotherapy and combined treatment modality in disseminated and locally advanced breast cancer.转移性和局部晚期乳腺癌的联合化疗及综合治疗模式
Prog Clin Biol Res. 1977;12:437-58.
9
Bilateral adrenalectomy for advanced breast cancer.双侧肾上腺切除术治疗晚期乳腺癌。
J R Coll Surg Edinb. 1975 Nov;20(6):374-9.
引用本文的文献
1
Clinical performance evaluation of O-Ring Halcyon Linac: A real-world study.O型环Halcyon直线加速器的临床性能评估：一项真实世界研究。
World J Clin Cases. 2022 Aug 6;10(22):7728-7737. doi: 10.12998/wjcc.v10.i22.7728.
2
Bone metastases in thyroid cancer.甲状腺癌的骨转移
J Bone Oncol. 2020 Feb 19;21:100282. doi: 10.1016/j.jbo.2020.100282. eCollection 2020 Apr.
3
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.ABAT和STC2表达降低是晚期雌激素受体阳性炎性乳腺癌和内分泌治疗耐药的特征。
Mol Oncol. 2015 Jun;9(6):1218-33. doi: 10.1016/j.molonc.2015.02.006. Epub 2015 Mar 4.
4
Imaging response to systemic therapy for bone metastases.全身治疗骨转移的影像学反应。
Eur Radiol. 2009 Oct;19(10):2495-507. doi: 10.1007/s00330-009-1443-1. Epub 2009 May 26.
5
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone.一项可行性研究，评估功能扩散图谱作为检测转移性前列腺癌骨转移患者治疗反应的预测性成像生物标志物。
Neoplasia. 2007 Dec;9(12):1003-11. doi: 10.1593/neo.07954.
6
Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.多柔比星每周给药联合5-氟尿嘧啶持续输注治疗晚期乳腺癌。
Br J Cancer. 1996 Dec;74(12):2008-12. doi: 10.1038/bjc.1996.668.
7
Chemotherapy of advanced breast cancer: outcome and prognostic factors.晚期乳腺癌的化疗：治疗结果与预后因素
Br J Cancer. 1993 Nov;68(5):988-95. doi: 10.1038/bjc.1993.467.
8
Radiographic evaluation of therapeutic response in bony metastases of breast cancer.乳腺癌骨转移治疗反应的影像学评估
Skeletal Radiol. 1981;7(3):159-65. doi: 10.1007/BF00361858.
Zotero 插件